Selected research
Market Structure
Global Gene Therapy Viral Packaging Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Therapy Viral Packaging Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Therapy Viral Packaging Service include GenScript, Abace Biology, Genecfps, GENEWIZ, Obio Technology, Charles River Laboratories, Takara Bio, abm and Cell Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Therapy Viral Packaging Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Therapy Viral Packaging Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Therapy Viral Packaging Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapy Viral Packaging Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Therapy Viral Packaging Service Segment by Company
GenScript
Abace Biology
Genecfps
GENEWIZ
Obio Technology
Charles River Laboratories
Takara Bio
abm
Cell Biolabs
Cyagen
Vector Biolabs
Lonza
Oxford BioMedica
Catalent
Wuxi Shengji Pharmaceuticals
Boten Biotech
Cytiva
Packgene
VectorBuilder
Ubigene
Gene Therapy Viral Packaging Service Segment by Type
Adeno-Associated Virus Packaging
Lentiviral Packaging
Adenovirus Packaging
Other
Gene Therapy Viral Packaging Service Segment by Application
Gene Therapy
Scientific Research
Gene Therapy Viral Packaging Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Viral Packaging Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Viral Packaging Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Viral Packaging Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapy Viral Packaging Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy Viral Packaging Service industry.
Chapter 3: Detailed analysis of Gene Therapy Viral Packaging Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Viral Packaging Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Adeno-Associated Virus Packaging
Table 3. Key Players of Lentiviral Packaging
Table 4. Key Players of Adenovirus Packaging
Table 3. Key Players of Other
Table 4. Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Gene Therapy
Table 6. Key Players of Scientific Research
Table 7. Global Gene Therapy Viral Packaging Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 8. Global Gene Therapy Viral Packaging Service Market Size by Region (2021-2026) & (US$ Million)
Table 9. Global Gene Therapy Viral Packaging Service Market Share by Region (2021-2026)
Table 10. Global Gene Therapy Viral Packaging Service Market Size by Region (2027-2032) & (US$ Million)
Table 11. Global Gene Therapy Viral Packaging Service Market Share by Region (2027-2032)
Table 12. Gene Therapy Viral Packaging Service Industry Trends
Table 13. Gene Therapy Viral Packaging Service Industry Drivers
Table 14. Gene Therapy Viral Packaging Service Industry Opportunities and Challenges
Table 15. Gene Therapy Viral Packaging Service Industry Restraints
Table 16. Global Gene Therapy Viral Packaging Service Revenue by Company (US$ Million) & (2021-2026)
Table 17. Global Gene Therapy Viral Packaging Service Revenue Market Share by Company (2021-2026)
Table 18. Global Gene Therapy Viral Packaging Service Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 19. Global Gene Therapy Viral Packaging Service Key Company Head Office and Area Served
Table 20. Global Gene Therapy Viral Packaging Service Company, Product Type & Application
Table 21. Global Gene Therapy Viral Packaging Service Company Establishment Date
Table 22. Global Company Market Concentration Ratio (CR5 and HHI)
Table 23. Global Gene Therapy Viral Packaging Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 24. Global Gene Therapy Viral Packaging Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 26. Global Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 27. Global Gene Therapy Viral Packaging Service Revenue Market Share by Type (2021-2026)
Table 28. Global Gene Therapy Viral Packaging Service Revenue Market Share by Type (2027-2032)
Table 29. Global Gene Therapy Viral Packaging Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 31. Global Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 32. Global Gene Therapy Viral Packaging Service Revenue Market Share by Application (2021-2026)
Table 33. Global Gene Therapy Viral Packaging Service Revenue Market Share by Application (2027-2032)
Table 34. GenScript Company Information
Table 35. GenScript Business Overview
Table 36. GenScript Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 37. GenScript Gene Therapy Viral Packaging Service Product Portfolio
Table 38. GenScript Recent Development
Table 39. Abace Biology Company Information
Table 40. Abace Biology Business Overview
Table 41. Abace Biology Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 42. Abace Biology Gene Therapy Viral Packaging Service Product Portfolio
Table 43. Abace Biology Recent Development
Table 44. Genecfps Company Information
Table 45. Genecfps Business Overview
Table 46. Genecfps Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 47. Genecfps Gene Therapy Viral Packaging Service Product Portfolio
Table 48. Genecfps Recent Development
Table 49. GENEWIZ Company Information
Table 50. GENEWIZ Business Overview
Table 51. GENEWIZ Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 52. GENEWIZ Gene Therapy Viral Packaging Service Product Portfolio
Table 53. GENEWIZ Recent Development
Table 54. Obio Technology Company Information
Table 55. Obio Technology Business Overview
Table 56. Obio Technology Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 57. Obio Technology Gene Therapy Viral Packaging Service Product Portfolio
Table 58. Obio Technology Recent Development
Table 59. Charles River Laboratories Company Information
Table 60. Charles River Laboratories Business Overview
Table 61. Charles River Laboratories Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 62. Charles River Laboratories Gene Therapy Viral Packaging Service Product Portfolio
Table 63. Charles River Laboratories Recent Development
Table 64. Takara Bio Company Information
Table 65. Takara Bio Business Overview
Table 66. Takara Bio Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 67. Takara Bio Gene Therapy Viral Packaging Service Product Portfolio
Table 68. Takara Bio Recent Development
Table 69. abm Company Information
Table 70. abm Business Overview
Table 71. abm Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 72. abm Gene Therapy Viral Packaging Service Product Portfolio
Table 73. abm Recent Development
Table 74. Cell Biolabs Company Information
Table 75. Cell Biolabs Business Overview
Table 76. Cell Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 77. Cell Biolabs Gene Therapy Viral Packaging Service Product Portfolio
Table 78. Cell Biolabs Recent Development
Table 79. Cyagen Company Information
Table 80. Cyagen Business Overview
Table 81. Cyagen Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 82. Cyagen Gene Therapy Viral Packaging Service Product Portfolio
Table 83. Cyagen Recent Development
Table 84. Vector Biolabs Company Information
Table 85. Vector Biolabs Business Overview
Table 86. Vector Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 87. Vector Biolabs Gene Therapy Viral Packaging Service Product Portfolio
Table 88. Vector Biolabs Recent Development
Table 89. Lonza Company Information
Table 90. Lonza Business Overview
Table 91. Lonza Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 92. Lonza Gene Therapy Viral Packaging Service Product Portfolio
Table 93. Lonza Recent Development
Table 94. Oxford BioMedica Company Information
Table 95. Oxford BioMedica Business Overview
Table 96. Oxford BioMedica Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 97. Oxford BioMedica Gene Therapy Viral Packaging Service Product Portfolio
Table 98. Oxford BioMedica Recent Development
Table 99. Catalent Company Information
Table 100. Catalent Business Overview
Table 101. Catalent Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 102. Catalent Gene Therapy Viral Packaging Service Product Portfolio
Table 103. Catalent Recent Development
Table 104. Wuxi Shengji Pharmaceuticals Company Information
Table 105. Wuxi Shengji Pharmaceuticals Business Overview
Table 106. Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 107. Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product Portfolio
Table 108. Wuxi Shengji Pharmaceuticals Recent Development
Table 109. Boten Biotech Company Information
Table 110. Boten Biotech Business Overview
Table 111. Boten Biotech Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 112. Boten Biotech Gene Therapy Viral Packaging Service Product Portfolio
Table 113. Boten Biotech Recent Development
Table 114. Cytiva Company Information
Table 115. Cytiva Business Overview
Table 116. Cytiva Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 117. Cytiva Gene Therapy Viral Packaging Service Product Portfolio
Table 118. Cytiva Recent Development
Table 119. Packgene Company Information
Table 120. Packgene Business Overview
Table 121. Packgene Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 122. Packgene Gene Therapy Viral Packaging Service Product Portfolio
Table 123. Packgene Recent Development
Table 124. VectorBuilder Company Information
Table 125. VectorBuilder Business Overview
Table 126. VectorBuilder Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 127. VectorBuilder Gene Therapy Viral Packaging Service Product Portfolio
Table 128. VectorBuilder Recent Development
Table 129. Ubigene Company Information
Table 130. Ubigene Business Overview
Table 131. Ubigene Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 132. Ubigene Gene Therapy Viral Packaging Service Product Portfolio
Table 133. Ubigene Recent Development
Table 134. North America Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 135. North America Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 136. North America Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 137. North America Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 138. North America Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 139. North America Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
Table 140. North America Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
Table 141. Europe Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 142. Europe Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 143. Europe Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 144. Europe Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 145. Europe Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 146. Europe Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
Table 147. Europe Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
Table 148. China Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 149. China Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 150. China Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 151. China Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 152. Asia Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 153. Asia Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 154. Asia Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 155. Asia Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 156. Asia Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 157. Asia Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
Table 158. Asia Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
Table 159. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Type (2021-2026) & (US$ Million)
Table 160. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Type (2027-2032) & (US$ Million)
Table 161. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Application (2021-2026) & (US$ Million)
Table 162. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Application (2027-2032) & (US$ Million)
Table 163. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 164. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
Table 165. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
Table 166. Research Programs/Design for This Report
Table 167. Authors List of This Report
Table 168. Secondary Sources
Table 169. Primary Sources
List of Figures
Figure 1. Gene Therapy Viral Packaging Service Product Image
Figure 2. Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Gene Therapy Viral Packaging Service Market Share by Type: 2025 VS 2032
Figure 4. Adeno-Associated Virus Packaging Image
Figure 5. Lentiviral Packaging Image
Figure 6. Adenovirus Packaging Image
Figure 7. Other Image
Figure 8. Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 9. Global Gene Therapy Viral Packaging Service Market Share by Application: 2025 VS 2032
Figure 10. Gene Therapy Image
Figure 11. Scientific Research Image
Figure 12. Global Gene Therapy Viral Packaging Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 13. Global Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 14. Global Gene Therapy Viral Packaging Service Market Share by Region: 2025 VS 2032
Figure 15. Years Considered
Figure 16. Global Gene Therapy Viral Packaging Service Market Share by Players in 2025
Figure 17. Global Top 5 and 10 Gene Therapy Viral Packaging Service Players Market Share by Revenue in 2025
Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Gene Therapy Viral Packaging Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Gene Therapy Viral Packaging Service Revenue Market Share by Type (2021-2032)
Figure 21. Global Gene Therapy Viral Packaging Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Gene Therapy Viral Packaging Service Revenue Market Share by Application (2021-2032)
Figure 23. North America Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 24. North America Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
Figure 25. North America Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
Figure 26. North America Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
Figure 27. United States Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 28. Canada Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 29. Mexico Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 30. Europe Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 31. Europe Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
Figure 32. Europe Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
Figure 33. Europe Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
Figure 34. Germany Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 35. France Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 36. U.K. Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 37. Italy Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 38. Russia Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 39. Nordic Countries Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 40. China Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 41. China Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
Figure 42. China Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
Figure 43. Asia Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 44. Asia Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
Figure 45. Asia Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
Figure 46. Asia Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
Figure 47. Japan Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 48. South Korea Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 49. Taiwan Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 51. India Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 52. Australia Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 53. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 54. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
Figure 55. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
Figure 56. South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
Figure 57. Brazil Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 58. South Africa Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 59. Saudi Arabia Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 60. Turkey Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 61. Argentina Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 62. UAE Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 63. Egypt Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 64. Chile Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 65. Research Process
Figure 66. Key Executives Interviewed
Scope & coverage.
Types
- Adeno-Associated Virus Packaging
- Lentiviral Packaging
- Adenovirus Packaging
- Other
Applications
- Gene Therapy
- Scientific Research
Companies covered
- GenScript
- Abace Biology
- Genecfps
- GENEWIZ
- Obio Technology
- Charles River Laboratories
- Takara Bio
- abm
- Cell Biolabs
- Cyagen
- Vector Biolabs
- Lonza
- Oxford BioMedica
- Catalent
- Wuxi Shengji Pharmaceuticals
- Boten Biotech
- Cytiva
- Packgene
- VectorBuilder
- Ubigene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Adeno-Associated Virus Packaging
- 1.2.3 Lentiviral Packaging
- 1.2.4 Adenovirus Packaging
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Therapy Viral Packaging Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gene Therapy
- 1.3.3 Scientific Research
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Therapy Viral Packaging Service Growth Trends by Region
- 1.5.1 Global Gene Therapy Viral Packaging Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Therapy Viral Packaging Service Market Size by Region (2021-2026)
- 1.5.3 Gene Therapy Viral Packaging Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Therapy Viral Packaging Service Market Dynamics
- 2.1 Gene Therapy Viral Packaging Service Industry Trends
- 2.2 Gene Therapy Viral Packaging Service Industry Drivers
- 2.3 Gene Therapy Viral Packaging Service Industry Opportunities and Challenges
- 2.4 Gene Therapy Viral Packaging Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Therapy Viral Packaging Service Revenue by Company (2021-2026)
- 3.2 Global Gene Therapy Viral Packaging Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Therapy Viral Packaging Service Key Company Head office and Area Served
- 3.4 Global Gene Therapy Viral Packaging Service Company, Product Type & Application
- 3.5 Global Gene Therapy Viral Packaging Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Therapy Viral Packaging Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Therapy Viral Packaging Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Therapy Viral Packaging Service Tier 1, Tier 2, and Tier 3
4 Gene Therapy Viral Packaging Service Market by Type
- 4.1 Global Gene Therapy Viral Packaging Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Therapy Viral Packaging Service Market Size by Type (2021-2032)
- 4.3 Global Gene Therapy Viral Packaging Service Market Size Share by Type (2021-2032)
5 Gene Therapy Viral Packaging Service Market by Application
- 5.1 Global Gene Therapy Viral Packaging Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Therapy Viral Packaging Service Market Size by Application (2021-2032)
- 5.3 Global Gene Therapy Viral Packaging Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 GenScript
- 6.1.1 GenScript Company Information
- 6.1.2 GenScript Business Overview
- 6.1.3 GenScript Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 GenScript Gene Therapy Viral Packaging Service Product Portfolio
- 6.1.5 GenScript Recent Developments
- 6.2 Abace Biology
- 6.2.1 Abace Biology Company Information
- 6.2.2 Abace Biology Business Overview
- 6.2.3 Abace Biology Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Abace Biology Gene Therapy Viral Packaging Service Product Portfolio
- 6.2.5 Abace Biology Recent Developments
- 6.3 Genecfps
- 6.3.1 Genecfps Company Information
- 6.3.2 Genecfps Business Overview
- 6.3.3 Genecfps Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Genecfps Gene Therapy Viral Packaging Service Product Portfolio
- 6.3.5 Genecfps Recent Developments
- 6.4 GENEWIZ
- 6.4.1 GENEWIZ Company Information
- 6.4.2 GENEWIZ Business Overview
- 6.4.3 GENEWIZ Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 GENEWIZ Gene Therapy Viral Packaging Service Product Portfolio
- 6.4.5 GENEWIZ Recent Developments
- 6.5 Obio Technology
- 6.5.1 Obio Technology Company Information
- 6.5.2 Obio Technology Business Overview
- 6.5.3 Obio Technology Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Obio Technology Gene Therapy Viral Packaging Service Product Portfolio
- 6.5.5 Obio Technology Recent Developments
- 6.6 Charles River Laboratories
- 6.6.1 Charles River Laboratories Company Information
- 6.6.2 Charles River Laboratories Business Overview
- 6.6.3 Charles River Laboratories Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Charles River Laboratories Gene Therapy Viral Packaging Service Product Portfolio
- 6.6.5 Charles River Laboratories Recent Developments
- 6.7 Takara Bio
- 6.7.1 Takara Bio Company Information
- 6.7.2 Takara Bio Business Overview
- 6.7.3 Takara Bio Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Takara Bio Gene Therapy Viral Packaging Service Product Portfolio
- 6.7.5 Takara Bio Recent Developments
- 6.8 abm
- 6.8.1 abm Company Information
- 6.8.2 abm Business Overview
- 6.8.3 abm Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 abm Gene Therapy Viral Packaging Service Product Portfolio
- 6.8.5 abm Recent Developments
- 6.9 Cell Biolabs
- 6.9.1 Cell Biolabs Company Information
- 6.9.2 Cell Biolabs Business Overview
- 6.9.3 Cell Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Cell Biolabs Gene Therapy Viral Packaging Service Product Portfolio
- 6.9.5 Cell Biolabs Recent Developments
- 6.10 Cyagen
- 6.10.1 Cyagen Company Information
- 6.10.2 Cyagen Business Overview
- 6.10.3 Cyagen Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Cyagen Gene Therapy Viral Packaging Service Product Portfolio
- 6.10.5 Cyagen Recent Developments
- 6.11 Vector Biolabs
- 6.11.1 Vector Biolabs Company Information
- 6.11.2 Vector Biolabs Business Overview
- 6.11.3 Vector Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Vector Biolabs Gene Therapy Viral Packaging Service Product Portfolio
- 6.11.5 Vector Biolabs Recent Developments
- 6.12 Lonza
- 6.12.1 Lonza Company Information
- 6.12.2 Lonza Business Overview
- 6.12.3 Lonza Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Lonza Gene Therapy Viral Packaging Service Product Portfolio
- 6.12.5 Lonza Recent Developments
- 6.13 Oxford BioMedica
- 6.13.1 Oxford BioMedica Company Information
- 6.13.2 Oxford BioMedica Business Overview
- 6.13.3 Oxford BioMedica Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Oxford BioMedica Gene Therapy Viral Packaging Service Product Portfolio
- 6.13.5 Oxford BioMedica Recent Developments
- 6.14 Catalent
- 6.14.1 Catalent Company Information
- 6.14.2 Catalent Business Overview
- 6.14.3 Catalent Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Catalent Gene Therapy Viral Packaging Service Product Portfolio
- 6.14.5 Catalent Recent Developments
- 6.15 Wuxi Shengji Pharmaceuticals
- 6.15.1 Wuxi Shengji Pharmaceuticals Company Information
- 6.15.2 Wuxi Shengji Pharmaceuticals Business Overview
- 6.15.3 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product Portfolio
- 6.15.5 Wuxi Shengji Pharmaceuticals Recent Developments
- 6.16 Boten Biotech
- 6.16.1 Boten Biotech Company Information
- 6.16.2 Boten Biotech Business Overview
- 6.16.3 Boten Biotech Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Boten Biotech Gene Therapy Viral Packaging Service Product Portfolio
- 6.16.5 Boten Biotech Recent Developments
- 6.17 Cytiva
- 6.17.1 Cytiva Company Information
- 6.17.2 Cytiva Business Overview
- 6.17.3 Cytiva Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Cytiva Gene Therapy Viral Packaging Service Product Portfolio
- 6.17.5 Cytiva Recent Developments
- 6.18 Packgene
- 6.18.1 Packgene Company Information
- 6.18.2 Packgene Business Overview
- 6.18.3 Packgene Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Packgene Gene Therapy Viral Packaging Service Product Portfolio
- 6.18.5 Packgene Recent Developments
- 6.19 VectorBuilder
- 6.19.1 VectorBuilder Company Information
- 6.19.2 VectorBuilder Business Overview
- 6.19.3 VectorBuilder Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 VectorBuilder Gene Therapy Viral Packaging Service Product Portfolio
- 6.19.5 VectorBuilder Recent Developments
- 6.20 Ubigene
- 6.20.1 Ubigene Company Information
- 6.20.2 Ubigene Business Overview
- 6.20.3 Ubigene Gene Therapy Viral Packaging Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Ubigene Gene Therapy Viral Packaging Service Product Portfolio
- 6.20.5 Ubigene Recent Developments
7 North America
- 7.1 North America Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 7.2 North America Gene Therapy Viral Packaging Service Market Size by Type
- 7.2.1 North America Gene Therapy Viral Packaging Service Market Size by Type (2021-2026)
- 7.2.2 North America Gene Therapy Viral Packaging Service Market Size by Type (2027-2032)
- 7.2.3 North America Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
- 7.3 North America Gene Therapy Viral Packaging Service Market Size by Application
- 7.3.1 North America Gene Therapy Viral Packaging Service Market Size by Application (2021-2026)
- 7.3.2 North America Gene Therapy Viral Packaging Service Market Size by Application (2027-2032)
- 7.3.3 North America Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
- 7.4 North America Gene Therapy Viral Packaging Service Market Size by Country
- 7.4.1 North America Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
- 7.4.3 North America Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
- 7.4.4 North America Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 8.2 Europe Gene Therapy Viral Packaging Service Market Size by Type
- 8.2.1 Europe Gene Therapy Viral Packaging Service Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Therapy Viral Packaging Service Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
- 8.3 Europe Gene Therapy Viral Packaging Service Market Size by Application
- 8.3.1 Europe Gene Therapy Viral Packaging Service Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Therapy Viral Packaging Service Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
- 8.4 Europe Gene Therapy Viral Packaging Service Market Size by Country
- 8.4.1 Europe Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 9.2 China Gene Therapy Viral Packaging Service Market Size by Type
- 9.2.1 China Gene Therapy Viral Packaging Service Market Size by Type (2021-2026)
- 9.2.2 China Gene Therapy Viral Packaging Service Market Size by Type (2027-2032)
- 9.2.3 China Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
- 9.3 China Gene Therapy Viral Packaging Service Market Size by Application
- 9.3.1 China Gene Therapy Viral Packaging Service Market Size by Application (2021-2026)
- 9.3.2 China Gene Therapy Viral Packaging Service Market Size by Application (2027-2032)
- 9.3.3 China Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 10.2 Asia Gene Therapy Viral Packaging Service Market Size by Type
- 10.2.1 Asia Gene Therapy Viral Packaging Service Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Therapy Viral Packaging Service Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
- 10.3 Asia Gene Therapy Viral Packaging Service Market Size by Application
- 10.3.1 Asia Gene Therapy Viral Packaging Service Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Therapy Viral Packaging Service Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
- 10.4 Asia Gene Therapy Viral Packaging Service Market Size by Country
- 10.4.1 Asia Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Therapy Viral Packaging Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst